Loading…
Established thought leaders with verified media credentials.
We deliver short, focused episodes on the main concepts and procedures you actually need to know. It’s the perfect clinical companion for your drive to work or your daily workout. Come learn IR on the go! Check us out at https://www.medicalwysdom.ai/
Unknown Host hosts Wysdom Radio™.
This episode pairs a 22-year Stanford retrospective of 1,094 lower extremity venous stents in 406 patients with the 3-year VIVO IDE trial of the Zilver Vena stent, and asks whether crossing the inguinal ligament actually
This episode tackles the "Goldilocks dilemma" of TIPS: finding the stent diameter that stops a life-threatening variceal bleed without silently destroying a patient's cognition. Listen to the end to hear the expert comme
This episode breaks down the 2024 ACG/Society of Abdominal Radiology consensus statement alongside a 2025 Duke University update, mapping out exactly which imaging test to reach for at each stage of a GI bleed and when I
This episode breaks down a 2026 JVIR retrospective study from the Mayo Clinic (Bretzman et al.), examining portal vein stent outcomes in 182 pancreatic cancer patients , and why the usual fixes for early stent failure ma
This episode unpacks a letters-to-the-editor debate sparked by the MOSAIC study (a Japanese multi-center trial in JVIR ) and turns it into a practical framework for reducing embolic stroke risk during transradial viscera
This episode breaks down two recent retrospective studies in deep venous work: a stent that looks well deployed on the table can still thrombose within weeks, because the low-flow venous system punishes any stasis. Follo
This episode breaks down a 2026 Journal of Vascular and Interventional Radiology Delphi consensus in which 14 international experts standardized the technical steps of prostatic artery embolization (PAE) for benign prost
This episode breaks down the 2026 AHA/ACC/ACCP/ACPPE pulmonary embolism guidelines, highlighting the biggest changes to PE risk stratification, catheter-based interventions, and long-term follow-up. It also discusses how
This episode breaks down a 2026 Journal of Vascular and Interventional Radiology prospective case series evaluating transarterial embolization (TAE) as a minimally invasive treatment for chronic, refractory plantar heel
This episode breaks down a comprehensive 2024 Journal of Urology review on prostate artery embolization (PAE) , exploring how it compares to transurethral resection of the prostate (TURP) and medical therapy for benign p
This episode breaks down a JVIR retrospective study on Thyroid Artery Embolization (TAE) , exploring whether embolization can serve as a non-surgical alternative for high-risk patients with massive retrosternal goiters w
This episode breaks down the newly published ARIVA trial ( Circulation ), a randomized study testing whether adding aspirin to rivaroxaban after post-thrombotic iliofemoral venous stenting actually improves stent patency
This episode breaks down the landmark C-TRACT trial ( NEJM 2026 ), a phase 3 randomized study testing whether iliac vein stenting plus enhanced antithrombotic therapy actually improves outcomes in patients with moderate-
This episode breaks down a randomized controlled trial from Hepatology exploring whether prophylactic embolization of large spontaneous portosystemic shunts (SPSS) during TIPS can prevent post-procedural hepatic encephal
This episode breaks down the landmark HI-PEITHO trial (NEJM, March 2026), a multicenter randomized controlled trial of 544 patients that finally brings clarity to the category of intermediate-risk PE. The Inclusion Crite
This brief covers a massive 950-patient study identifying how to predict Post-TIPS Liver Failure (PTLF), which occurs in approximately 18% of cases . The 18% Problem: With nearly 1 in 5 patients failing after TIPS, this
This episode highlights the MILESTONE study , a ground-breaking first-in-human trial presented at the Society of Interventional Radiology (SIR) 2026 Annual Meeting . The research explores a novel endovascular approach to
The COLLISION Explained This episode breaks down the practice-changing COLLISION Trial (Lancet Oncology, 2025) and explores how the IR community must scale its skills to meet the new standard of care. The Mic Drop: For d
AHA/ACC 2026 Guidelines for the Evaluation and Management of Acute Pulmonary Embolism The alphabet soup of societies (AHA/ACC/ACCP/ACP) has officially released the 2026 Multi-Society PE Guidelines. These guidelines move
Stanford IR's Dr. Lynne Martin on PAVM Treatment This episode covers the critical paradigm shift in treating Pulmonary Arteriovenous Malformations (PAVMs) as detailed by Dr. Lynne Martin from Stanford Interventional Radi
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Wysdom Radio™ has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Wysdom Radio™ is hosted by Unknown Host. The show is categorised under Health (fitness) and has published 0 episodes.
Wysdom Radio™ regularly covers Health, Fitness, Medicine. It sits in the Health category, with a fitness focus.
Wysdom Radio™ is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Wysdom Radio™ hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Wysdom Radio™ average 16 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Wysdom Radio™'s guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 5 days ago.